Am J Transplant, Volume 19, Suppl 3 Archives - Page 195 of 214 - ATC Abstracts

2019 American Transplant Congress
Impact Of Rituximab And Maintenance Steroid In The Recurrence Of Focal Segmental Glomerulosclerosis
L. A. Mendez Castaner
Transplant, Miami Transplant Institute-University of Miami, Miami, FL
*Purpose: Recurrence of focal segmental glomerulosclerosis (FSGS) has been reported between 20-80% with up to 60% of graft loss. Rituximab has demonstrated to be effective…
2019 American Transplant Congress
Effect of Induction Therapy on Absolute CD4 Count and CD4 Percentage in HIV Positive Kidney Transplant Recipients
S. A. Kuten¹, I. E. Dunne¹, A. E. Cantwell¹, M. J. Hobeika², S. G. Yi², W. Musick¹, R. J. Knight², A. O. Gaber²
¹Pharmacy, Houston Methodist Hospital, Houston, TX, ²Surgery, Houston Methodist Hospital, Houston, TX
*Purpose: Anti-thymocyte globulin (ATG) induction causes profound and long-lasting lymphocyte depletion, with CD4+ reconstitution lagging behind other subsets. While absolute CD4 count is the preferred…
2019 American Transplant Congress
Post-Donation Hypertension is Highly Associated with Estimated Nephron Number, Post-Donation Weight Gain, and Family History: A Prospective 5-Year Follow-Up after Living Kidney Donation
T. Schachtner¹, N. M. Otto², P. Reinke²
¹University Hospital Zurich, Zurich, Switzerland, ²Charite University Medicine Berlin, Zurich, Germany
*Purpose: The rising prevalence of end-stage renal disease and chronic organ shortage subsequently calls more people upon to consider living kidney donation. Recent data, however,…
2019 American Transplant Congress
The Outcomes of Living Donor Kidney Transplantation in Donors or Recipients with Donors’ Renal Arteriosclerotic Lesions on Preoperative Computed Tomography
Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika
Ehime University, Toon, Japan
*Purpose: Living donor kidney transplantation is being increasingly performed with elderly donors. Such elderly donors often have arteriosclerotic lesions (AS) (Figure 1). Whether the outcomes…
2019 American Transplant Congress
Outcomes after Incompatible Living Donor Kidney Transplantation in Older Recipients
J. Long¹, K. Jackson¹, J. Motter¹, S. Bae¹, A. Massie¹, M. Waldram¹, K. Covarrubias¹, J. Chen¹, B. Orandi², N. Desai¹, D. Segev¹, J. Garonzik-Wang¹
¹Johns Hopkins School of Medicine, Baltimore, MD, ²Surgery, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Older individuals are the fastest-growing sub-group of transplant candidates who may face increased risks when considering incompatible living donor kidney transplantation (IKT) due to…
2019 American Transplant Congress
Mitigating Racial and Gender Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation’s Longest Single-Center Kidney Chain
M. N. Mustian, V. Kumar, K. Stegner, D. Mompoint-Williams, M. Hanaway, M. H. Deierhoi, C. Young, B. Orandi, D. Anderson, P. A. MacLennan, R. D. Reed, B. A. Shelton, D. Eckhoff, J. E. Locke
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Disparities in access to living donor kidney transplantation (LDKT) exist among minorities and women and may be partially explained by antigen sensitization secondary to…
2019 American Transplant Congress
Allograft Quality Impacts Simultaneous Liver Kidney Transplant Survival Outcomes in Recipients That Undergo Liver Re-Transplantation
J. Reyes, M. Eerhart, C. Blanton, P. Chlebeck, E. Polyak, Y. Yankol, L. Fernandez
Department of Surgery, University of Wisconsin - Madison, Madison, WI
*Purpose: The only effective therapeutic strategy for irreversible liver graft failure is re-transplantation. The impact of liver and kidney quality in secondary SLK (sSLK) survival…
2019 American Transplant Congress
Multidisciplinary Practitioner Perspectives on Cardiovascular Disease Guideline Interventions in Liver Transplant Recipients
M. Kosirog¹, L. Adamski¹, A. Daud², D. Finn², D. Gregory¹, D. M. Lloyd-Jones³, J. L. Holl⁴, L. B. VanWagner⁵
¹Medicine-GI & Hepatology, Northwestern University, Chicago, IL, ²Center for Healthcare Studies, Northwestern University, Chicago, IL, ³Medicine-Cardiology and Preventive Medicine, Northwestern University, Chicago, IL, ⁴Pediatrics & Center for Healthcare Studies, Northwestern University, Chicago, IL, ⁵Medicine-GI & Hepatology and Preventive Medicine, Northwestern University, Chicago, IL
*Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in liver transplant recipients (LTRs). However, there is a lack of LT-specific CVD clinical practice…
2019 American Transplant Congress
Totally Robotic Donor Hepatectomy: Feasibility And Early Outcomes
Y. Cheah, C. J. Simon, W. D. Lewis, R. L. Jenkins, M. E. Akoad
Lahey Hospital & Medical Center, Burlington, MA
*Purpose: Robotic surgery is emerging as a surgical technique to enable resection of the liver using minimally invasive techniques; however, very few living donor liver…
2019 American Transplant Congress
Activation of Renal Fibroblasts by Anti- Major Histocompatibility Complex Antibody: A Missing Link in Allograft Fibrosis
M. B. Oliver¹, J. Chen², A. Zmijewska¹, R. B. Mannon¹
¹Medicine, Division of Nephrology, The University of Alabama at Birmingham, Birmingham, AL, ²Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, The University of Alabama at Birmingham, Birmingham, AL
*Purpose: Chronic antibody-mediated rejection (CAMR) is an important contributor to late kidney allograft loss, frequently accompanied by interstitial fibrosis and tubular atrophy. Donor-specific antibodies (DSA)…